Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 16:05 ET | Source: Atsena Therapeutics

Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026

12-month results from Part A of LIGHTHOUSE Trial reinforce ATSN-201's favorable safety profile and durable structural and functional benefits in patients with X-linked retinoschisis Three-year data...
May 07, 2026 10:34 ET | Source: Zoomex

Zoomex X Space Recap With Ollie Bearman and Crypto KOLs

VICTORIA, Seychelles, May 07, 2026 (GLOBE NEWSWIRE) -- Zoomex hosted a two-part X Space around its “Speed You Can Trust” theme, bringing Formula 1 and crypto trading into one conversation....
May 07, 2026 09:30 ET | Source: Multidisciplinary Association for Psychedelic Studies (MAPS)

MAPS Welcomes Liana Gillooly and Andrew "Mo" Septimus to Board of Directors

Liana Sananda Gillooly and Andrew "Mo" Septimus have been elected to the MAPS Board of Directors, bringing complementary expertise across the psychedelic field, ethical business governance, and...
May 07, 2026 09:19 ET | Source: Research and Markets

Elzonris (Menarini Group) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Elzonris Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
May 07, 2026 09:00 ET | Source: KALA BIO, Inc.

KALA BIO Announces Reverse Stock Split

ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock,...
May 07, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
May 07, 2026 08:00 ET | Source: SERB Pharmaceuticals

SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US

SERB Pharmaceuticals announced that ThyroSafe potassium iodide tablets are now commercially available in a 130 mg dose.
May 07, 2026 07:30 ET | Source: One Bullion Ltd.

One Bullion Reports Gravity-Finish Assay Results at Vumba Project, Including 30.8 g/t Au, and Receives EIA Approval for Maitengwe Project

Gravity-Finish Re-Assay Confirms High-Grade Gold Mineralization at Vumba; Four of Five Previously Reported Overlimit Sample Return Greater Than 10 g/t Au EIA Approval Received from Botswana's...
May 07, 2026 07:22 ET | Source: MarketWise LLC

MarketWise Reports Net Revenue of $77.0 Million and Net Loss of $0.6 Million for First Quarter 2026; Q1 Billings Increase 15% YoY; Announced Quarterly Regular and Special Dividends totaling $0.45 per Class A share; Affirms FY 2026 Guidance of Billings of $300 Million and CFFO of $50 Million; Board Authorizes New $50M Share Buyback Program

BALTIMORE, May 07, 2026 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium...
May 07, 2026 07:00 ET | Source: Westhaven Gold Corp.

Westhaven Returns 54m Grading 8.99 g/t Au & 55 g/t Ag from Resource In-Fill Drilling and Initiates South Zone Pre-Feasibility Study, Shovelnose Gold and Silver Project, Southern British Columbia

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) is pleased to provide an update on its 2026 field...